ProQR Therapeutics N.V.
ProQR Therapeutics N.V. (PRQR) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
prqr · stock forecast · 10 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 10 Wall Street analysts in the past 3 months
Buy
10 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$5.00
Consensus
$3.63
+137.3% upside
Low
$2.00
Median: $3.75 · Last Close: $1.53
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$3.63
137.3% upside
High Target
$5
226.8%
Low Target
$2
30.7%
Current Price
$1.53
as of today
Based on analyst price targets, the PRQR stock price prediction for the next 12 months ranges from $2 to $5. The consensus PRQR price forecast of $3.63 implies 137.3% upside from the current price of $1.53.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.50 | ↓ 1.66% |
1-day model range: $1.49–$1.52. Peak: $1.52 (-1.66%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -50.0% |
| 2028 | $1 | -62.5% |
| 2029 | $1 | -67.2% |
| 2030 | $0 | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PRQR · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-09 | Chardan Capital | Maintains | Buy→Buy |
| 2025-11-04 | Chardan Capital | Maintains | Buy→Buy |
| 2025-08-08 | Chardan Capital | Maintains | Buy→Buy |
| 2025-06-27 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-06-27 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2025-05-13 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-03-14 | Chardan Capital | Maintains | Buy→Buy |
| 2025-03-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-12-12 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2024-12-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on ProQR Therapeutics N.V. (PRQR) stock. Of the recent 47 rating actions, 4 were upgrades and 2 were downgrades. 10 analysts currently cover PRQR.
Analyst Recommendation Trends
PRQR analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$21M
↓ 64.8% YoY
Revenue Next Year
$17M
↓ 18.6% YoY
EPS This Year
$-0.52
EPS Next Year
$-0.60
↑ 15.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast PRQR EPS of $-0.52 for the current fiscal year, based on estimates from 4 analysts. The PRQR revenue forecast is $21M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PRQR stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PRQR price target is $3.63 (+137.3% upside), with an analyst consensus of Buy.
The PRQR short-term stock prediction for tomorrow is $1.50 (-1.66%). The PRQR stock price prediction for 2027 estimates an average of $1. The PRQR stock prediction for 2030 projects a range of $0–$1.
ProQR Therapeutics N.V. trades on NASDAQ under the ticker PRQR. The PRQR stock outlook for 2027 is broadly positive, supported by a Buy consensus among 90% of covering analysts.
Frequently asked questions
PRQR forecast · 8 questionsAccording to 10 Wall Street analysts, the average 12-month PRQR price target is $3.63, with a high forecast of $5.00 and a low of $2.00. The median price target is shown in the chart above when available. This implies +137.3% potential upside from the current price of $1.53.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.